Genetic Basis of Multidrug-resistant Acinetobacter baumannii Clinical Isolates from Three University Hospitals in Chungcheong Province, Korea
1
조회
0
다운로드
13
인용
0
참고문헌
키워드
초록
Background: The emergence of multidrug-resistant (MDR) Acinetobacter baumannii as an important opportunistic pathogen has given rise to significant therapeutic challenges in the treatment of nosocomial infections. In the present study, we assess the antibiotic resistance mechanisms of MDR A. baumannii strains by estimating the prevalence of antibiotic resistance determinants, including integrons, b-lactamases, str genes, and gyrA and parC mutations. Methods: Thirty-five MDR A. baumannii clinical isolates were collected from 3 Korean university hospitals over a 2-yr period. A. baumannii was confirmed by rpoB gene analysis. For each isolate, the minimal inhibitory concentrations (MICs) of 9 antibiotics were determined by the agar dilution method. PCR and DNA sequencing were used to identify the genes that potentially contribute to each resistance phenotype. Results: Of the 35 MDR A. baumannii isolates examined, 7 antibiotic resistance gene determinants were detected. These resistance gene determinants included the gene blaOXA-23, with an upstream element ISAba1 to promote increased gene expression and subsequent resistance to carbapenems, in 8 isolates (22.9%); aacA4, located within class 1 integrons, in 7 isolates (20.0%); and fluoroquinolone resistance conferred by gyrA and parC sense mutations in 31 isolates. Conclusions: Of the 35 MDR A. baumannii isolates, 26 (74.3%) from both outbreak and sporadic cases possessed at least 4 of the 7 antibiotic resistance gene determinants that give rise to the MDR phenotype. The co-occurrence of several resistance determinants may present a significant threat. (Korean J Lab Med 2010;30:498-506)
Abstract
Background: The emergence of multidrug-resistant (MDR) Acinetobacter baumannii as an important opportunistic pathogen has given rise to significant therapeutic challenges in the treatment of nosocomial infections. In the present study, we assess the antibiotic resistance mechanisms of MDR A. baumannii strains by estimating the prevalence of antibiotic resistance determinants, including integrons, b-lactamases, str genes, and gyrA and parC mutations. Methods: Thirty-five MDR A. baumannii clinical isolates were collected from 3 Korean university hospitals over a 2-yr period. A. baumannii was confirmed by rpoB gene analysis. For each isolate, the minimal inhibitory concentrations (MICs) of 9 antibiotics were determined by the agar dilution method. PCR and DNA sequencing were used to identify the genes that potentially contribute to each resistance phenotype. Results: Of the 35 MDR A. baumannii isolates examined, 7 antibiotic resistance gene determinants were detected. These resistance gene determinants included the gene blaOXA-23, with an upstream element ISAba1 to promote increased gene expression and subsequent resistance to carbapenems, in 8 isolates (22.9%); aacA4, located within class 1 integrons, in 7 isolates (20.0%); and fluoroquinolone resistance conferred by gyrA and parC sense mutations in 31 isolates. Conclusions: Of the 35 MDR A. baumannii isolates, 26 (74.3%) from both outbreak and sporadic cases possessed at least 4 of the 7 antibiotic resistance gene determinants that give rise to the MDR phenotype. The co-occurrence of several resistance determinants may present a significant threat. (Korean J Lab Med 2010;30:498-506)
참고문헌 (28)
- Bergogne-Berezin E, "Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features", Clin Microbiol Rev, 9, pp.148~165 (1996)
- Petersen A, "Class I integrons containing a dhfrI trimethoprim resistance gene cassette in aquatic Acinetobacter spp", FEMS Microbiol Lett, 182, pp.73~76 (2000)
- Recchia GD, "Gene cassettes: a new class of mobile element", Microbiology, 141, pp.3015~3027 (1995)
- Srinivasan VB, "Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA", Ann Clin Microbiol Antimicrob, 8, pp.21~ (2009)
- 성지연, "IMP-1과 OXA -lactamase를 생성하는 Carbapenem 내성 Acinetobacter baumanni 의 확산", The Korean Journal of Laboratory Medicine, 28(1), pp.16~23 (2008), 대한진단검사의학회
- Nemec A, "Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones", J Med Microbiol, 53, pp.1233~1240 (2004)
- Poirel L, "Carbapenemases: molecular diversity and clinical consequences", Future Microbiol, 2, pp.501~512 (2007)
- Afzal-Shah M, "Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii", Antimicrob Agents Chemother, 45, pp.583~588 (2001)
- Naas T, "Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia", J Clin Microbiol, 43, pp.4826~4829 (2005)
- Mugnier PD, "Functional analysis of insertion sequence ISAba1, responsible for genomic plasticity of Acinetobacter baumannii", J Bacteriol, 191, pp.2414~2418 (2009)
- Vila J, "Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii", Antimicrob Agents Chemother, 39, pp.1201~1203 (1995)
- 이미애, "다제내성 Acinetobacter baumannii 균주의 항균제 병합 효과", The Korean Journal of Laboratory Medicine, 25(5), pp.312~316 (2005), 대한진단검사의학회
- Ko KS, "High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea", J Antimicrob Chemother, 60, pp.1163~1167 (2007)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing. 17th informational supplement. M100-S17", Clinical and Laboratory Standards Institute, ~ (2007)
- Mak JK, "Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii", J Antimicrob Chemother, 63, pp.47~54 (2009)
- Woodford N, "Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp", Int J Antimicrob Agents, 27, pp.351~353 (2006)
- Vila J, "Jimenez de Anta T. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii", Antimicrob Agents Chemother, 39, pp.1201~1203 (1995)
- Valentine SC, "Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California", J Clin Microbiol, 46, pp.2499~2507 (2008)
- 신소연, "Characteristics of aac(6′)-Ib-cr Gene in Extended-Spectrum b-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolated from Chungnam Area", The Korean Journal of Laboratory Medicine, 29(6), pp.541~550 (2009), 대한진단검사의학회
- Bou G, "PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsedfield gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii", Clin Microbiol Infect, 6, pp.635~643 (2000)
- Turton JF, "The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii", FEMS Microbiol Lett, 258, pp.72~77 (2006)
- Gallego L, "Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain", J Med Microbiol, 50, pp.71~77 (2001)
- Gombac F, "Molecular characterization of integrons in epidemiologically unrelated clinical isolates of Acinetobacter baumannii from Italian hospitals reveals a limited diversity of gene cassette arrays", Antimicrob Agents Chemother, 46, pp.3665~3668 (2002)
- Turton JF, "Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom", J Clin Microbiol, 43, pp.3074~3082 (2005)
- Heritier C, "Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii", Clin Microbiol Infect, 12, pp.123~130 (2006)
- Corvec S, "AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains", J Antimicrob Chemother, 52, pp.629~635 (2003)
- Akasaka T, "Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance", Antimicrob Agents Chemother, 45, pp.2263~2268 (2001)
- Lee JK, "Mutations in the gyrA and parC genes in ciprofloxacin-resistant clinical isolates of Acinetobacter baumannii in Korea", Microbiol Immunol, 49, pp.647~653 (2005)